Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Autoimmune Disorders

Free Subscription 27.10.2025 1 Am J Kidney Dis 1 Ann Neurol 9 Diabet Med 5 Diabetes 1 Intern Med 2 J Neuroimmunol 5 J Neurol 1 Kidney Int 3 Mult Scler 1 N Engl J Med 7 Neurology 2 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Kidney Dis

1. ZAND L, Fervenza FC, Sethi S
   What's New in Membranous Nephropathy and How to Incorporate New Antigen Discoveries into Clinical Practice?
   Am J Kidney Dis. 2025 Oct 17:S0272-6386(25)01079.
   PubMed         Abstract available
   
   

   
   Ann Neurol

2. FISSE AL, Bonberg N, Beuker C, Pfeuffer C, et al
   Disease Characteristics and Treatments Associated with Outcome in Primary Angiitis of the Central Nervous System-A Multicenter Cohort Study in 163 Patients.
   Ann Neurol. 2025;98:883-893.
   PubMed         Abstract available
   
   

   
   Diabet Med

3. BOGGISS AL, Babbott K, Milford A, Ellett S, et al
   The usability and feasibility of a self-compassion chatbot (COMPASS) for youth living with type 1 diabetes.
   Diabet Med. 2025 Jul 27:e70115. doi: 10.1111/dme.70115.
   PubMed         Abstract available
   
   
4. DONIS R, Wakeling MN, Jeffery N, Govier M, et al
   Neonatal diabetes mellitus is a significant feature of COXPD-24 caused by recessive NARS2 variants.
   Diabet Med. 2025 Aug 31:e70129. doi: 10.1111/dme.70129.
   PubMed         Abstract available
   
   
5. SEIDU S, Tetteh J, Kunutsor S, Choudhary P, et al
   Prescription distribution and inequities in diabetes care: A comparative analysis of continuous glucose monitoring access by diabetes status, ethnicity and socio-economic factors in England.
   Diabet Med. 2025 Sep 3:e70130. doi: 10.1111/dme.70130.
   PubMed         Abstract available
   
   
6. AMED S, Bone JN, Kishore SB, Zhang Q, et al
   A longitudinal cohort study describing childhood type 1 diabetes incidence and prevalence rates in British Columbia, Canada over 27 years (1997-2023).
   Diabet Med. 2025 Sep 9:e70133. doi: 10.1111/dme.70133.
   PubMed         Abstract available
   
   
7. HEYMAN E, Peters TM, Lespagnol E, Parent C, et al
   Exploring gender differences in physical activity and related barriers in children and adults living with type 1 diabetes: A narrative review.
   Diabet Med. 2025 Sep 9:e70132. doi: 10.1111/dme.70132.
   PubMed         Abstract available
   
   
8. STIMSON RH, Strachan MWJ, Forbes S, Wright RJ, et al
   Impact of Omnipod 5 automated insulin delivery on continuous glucose monitoring metrics and predictors of improvement in time in range.
   Diabet Med. 2025;42:e70137.
   PubMed         Abstract available
   
   
9. HARRISON A, Zaremba N, Brown J, Pillay D, et al
   A quantitative process evaluation of a feasibility randomised controlled trial of a co-designed cognitive behavioural therapy intervention for people with type 1 diabetes and disordered eating (steady trial): Auditing treatment integrity and delivery.
   Diabet Med. 2025 Sep 12:e70124. doi: 10.1111/dme.70124.
   PubMed         Abstract available
   
   
10. DEN BROK EJ, Hornborg-Svensson C, Dimitropoulou NM, Broeng-Mikkelgaard S, et al
    Study protocol for exploring diabetes numeracy and health literacy across Europe (EDUCATE): A multicentre cross-sectional study.
    Diabet Med. 2025 Sep 18:e70140. doi: 10.1111/dme.70140.
    PubMed         Abstract available
    
    
11. BESSER REJ, Campbell F, Damazer K, Elleri D, et al
    UK best practice recommendations for children and young people <18 years with pre-stage 3 type 1 diabetes, on behalf of the British Society for Paediatric Endocrinology and Diabetes (BSPED).
    Diabet Med. 2025 Sep 23:e70117. doi: 10.1111/dme.70117.
    PubMed         Abstract available
    
    

    
    Diabetes

12. FLAMMER ER, Christopher MW, Powers ER, Broncucia H, et al
    Serum Metabolomics Reveals Potential Differences in Gut Microbiota-Associated Metabolites in Twins Discordant for Type 1 Diabetes.
    Diabetes. 2025 Sep 11:db250156. doi: 10.2337/db25-0156.
    PubMed         Abstract available
    
    
13. BLOM SE, Narsian PR, Behan-Bush RM, Ankrum JA, et al
    Proinflammatory Cytokines Mediate Pancreatic beta-Cell-Specific Alterations to Golgi Integrity via iNOS-Dependent Mitochondrial Inhibition.
    Diabetes. 2025;74:1992-2007.
    PubMed         Abstract available
    
    
14. SIMS EK, Russell WE, Cuthbertson D, Skyler JS, et al
    Novel Approach for Assessing Outcomes of Type 1 Diabetes Prevention Trials Over a Fixed Time Interval.
    Diabetes. 2025 Aug 28:db250310. doi: 10.2337/db25-0310.
    PubMed         Abstract available
    
    
15. REYNOLDS KM, Sun Q, Zhang Y, Umans J, et al
    Diabetes Genetic Clusters and Clinical Outcomes in American Indians.
    Diabetes. 2025 Aug 18:db250322. doi: 10.2337/db25-0322.
    PubMed         Abstract available
    
    
16. DROTAR DM, Vazquez Ramos GJA, Williams MD, David ST, et al
    Loss of Insulin-Positive Cell Clusters Precedes the Decrease in Islet Frequency and beta-Cell Area in Type 1 Diabetes.
    Diabetes. 2025 Jul 24:db250326. doi: 10.2337/db25-0326.
    PubMed         Abstract available
    
    

    
    Intern Med

17. NAKATA Y, Mori T, Nogami A
    Paroxysmal Nocturnal Hemoglobinuria in Patients with Systemic Lupus Erythematosus: Diagnostic Challenges and Improvement with C5 Inhibitor Treatment.
    Intern Med. 2025 Oct 23. doi: 10.2169/internalmedicine.6119.
    PubMed         Abstract available
    
    

    
    J Neuroimmunol

18. GE F, Song B, Wang X, Tian M, et al
    Association of thyroid autoimmune status with Alzheimer's disease biomarkers in euthyroid subjects.
    J Neuroimmunol. 2025;409:578780.
    PubMed         Abstract available
    
    
19. ZHANG Z, Chen K, Qiu H, Ke S, et al
    GD3 antibody subtyping reveals central-peripheral dichotomy in autoimmune neurological disorders.
    J Neuroimmunol. 2025;409:578771.
    PubMed         Abstract available
    
    

    
    J Neurol

20. PREZIOSA P, Brescia Morra V, Capobianco M, Gasperini C, et al
    Efficacy and safety of ublituximab for relapsing multiple sclerosis patients: current evidence and expert opinion.
    J Neurol. 2025;272:707.
    PubMed         Abstract available
    
    
21. SU X, Zheng Z, Yu F, Liu C, et al
    The impact of different exercise types on cognitive function in patients with multiple sclerosis: a systematic review and network meta-analysis.
    J Neurol. 2025;272:709.
    PubMed         Abstract available
    
    
22. OPFER R, Spies L, Kruger J, Buddenkotte T, et al
    Whole brain volume loss is associated with a short-term disability progression in relapse-activity free multiple sclerosis.
    J Neurol. 2025;272:715.
    PubMed         Abstract available
    
    
23. LATINI E, Guida M, Zirafa CC, Rizzo S, et al
    Long-term effectiveness of thymectomy in late-onset myasthenia gravis.
    J Neurol. 2025;272:714.
    PubMed         Abstract available
    
    
24. ABOSEIF A, Jackson-Tarlton CS, Schwarz CG, Decker PA, et al
    Cervical cord atrophy correlates with intracranial lesion burden in tumefactive multiple sclerosis.
    J Neurol. 2025;272:717.
    PubMed         Abstract available
    
    

    
    Kidney Int

25. LIU S, Wu X
    Considerations for fairness and practicality in deep learning model predicting treatment response in lupus nephritis.
    Kidney Int. 2025;108:948.
    PubMed        
    
    

    
    Mult Scler

26. REINSBERG HK, Oertel FC, Casillas D, Kaufhold G, et al
    Investigating the impact of age on neurodegeneration after optic neuritis in multiple sclerosis using optical coherence tomography.
    Mult Scler. 2025;31:1493-1505.
    PubMed         Abstract available
    
    
27. PAISEY C, Curtin K, Epps SJ, Rice CM, et al
    Acute retinal necrosis associated with dimethyl fumarate.
    Mult Scler. 2025;31:1506-1508.
    PubMed         Abstract available
    
    
28. FREEDMAN DE, Campbell KA, Feinstein A
    Affective reserve in multiple sclerosis.
    Mult Scler. 2025;31:1397-1400.
    PubMed        
    
    

    
    N Engl J Med

29. RAHIMOV F, Jacobs BM, Lee JS, Mahi NA, et al
    Common Diseases in Clinical Cohorts - Not Always What They Seem.
    N Engl J Med. 2025;393:1589-1598.
    PubMed         Abstract available
    
    

    
    Neurology

30. FENG Q
    Reader Response: Cancer Risk Among Patients With Multiple Sclerosis: A 10-Year Nationwide Retrospective Cohort Study.
    Neurology. 2025;105:e210223.
    PubMed        
    
    
31. SONG Y, Wang L, Xuan Z
    Reader Response: Cancer Risk Among Patients With Multiple Sclerosis: A 10-Year Nationwide Retrospective Cohort Study.
    Neurology. 2025;105:e210222.
    PubMed        
    
    
32. SEJVAR JJ
    Guillain-Barre Syndrome: Grasping the "Rarity" of Outbreaks.
    Neurology. 2025;105:e214268.
    PubMed        
    
    
33. GANESH A, Galetta SL
    Editors' Note: Understanding Cancer Risk Among Patients With Multiple Sclerosis.
    Neurology. 2025;105:e214342.
    PubMed        
    
    
34. PIERRET C, Leray E
    Author Response: Cancer Risk Among Patients With Multiple Sclerosis: A 10-Year Nationwide Retrospective Cohort Study.
    Neurology. 2025;105:e210260.
    PubMed        
    
    
35. DIMAURO KA, Manohar N, Aboseif A, Shah C, et al
    Leucine Zipper 4 Autoantibody-Associated Myeloneuropathy With Multiple Cranial Neuropathies and Longitudinally Extensive Tractopathy.
    Neurology. 2025;105:e214384.
    PubMed        
    
    
36. VOROBYEV A, Buciuc M, Perez Giraldo GS, Grewal P, et al
    Clinical Reasoning: A 56-Year-Old Woman With Right-Sided Weakness and Recurrent MRI Lesions.
    Neurology. 2025;105:e214293.
    PubMed         Abstract available
    
    

    
    PLoS One

37. OGUZ-AKARSU E, Lazrak SEH, Sigirli D, Gullu G, et al
    Myasthenia gravis and autoimmune overlap: Prognostic insight.
    PLoS One. 2025;20:e0334434.
    PubMed         Abstract available
    
    
38. FRAGOZO-RAMOS MC, Schenker G, Hepprich M, Gallo-Villegas J, et al
    GIP/GLP-1RA as adjunctive to automated insulin delivery in adults with Type 1 diabetes (the AID-JUNCT trial): Study protocol for a prospective, randomized, clinical trial.
    PLoS One. 2025;20:e0335060.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

39. BAYER AC, Sanmarco LM, Pellerin A, Masi G, et al
    Therapeutic IgG- and IgM-specific proteases disarm the acetylcholine receptor autoantibodies that drive myasthenia gravis pathology.
    Proc Natl Acad Sci U S A. 2025;122:e2505984122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.